A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting

Phase 3

TAK-279A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Sponsor:

Takeda

Code:

NCT06550076

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-279

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Takeda on 2025-04-17.